Edward H. Giannini, MSc, DrPH

Professor Emeritus, UC Department of Pediatrics

Phone 513-636-7634

Email edward.giannini@cchmc.org

Dr. Giannini is a master of the American College of Rheumatology. In 2002 he was awarded the Arthritis Foundation’s Virginia P. Engalitcheff Award for Impact on Quality of Life of Persons with Arthritis. In 2011 he was named the Distinguished Clinical Investigator of the Year by the American College of Rheumatology.

MSc: Arizona State University, Tempe, AZ, 1975.

DrPH: University of Texas School of Public Health, Houston, TX, 1978.

Giannini EH, Ilowite NT, Lovell DJ et al. Effects of long-term etanercept on growth in children with selected categories of juvenile idiopathic arthritis. Arthritis and Rheumatism. 2010;62:3259-3264.

Giannini EH, Mehta AB, Milz MJ, et al. A validated disease severity scoring system for Fabry Disease. Molecular Genetics and Metabolism. 2010;99:283-290.

Lovell DJ, Ruperto N, Goodman S.Giannini EH, Martini A. A randomized, placebo-controlled trial of adalimumab with or without methotrexate in children with polyarticular juvenile rheumatoid arthritis. New England Journal of Medicine. 2008;359:810-820.

Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck B, for the Pediatric Rheumatology Collaborative Study Group. Etanercept in children with polyarticular-course juvenile rheumatoid arthritis. New England Journal of Medicine. 2000;342:763-769.

Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis and Rheumatism. 1997;40:1202-1209.

Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT, Zemel LS, for the Pediatric Rheumatology Collaborative Study Group and the Cooperative Children's Study Group: Methotrexate treatment of recalcitrant juvenile rheumatoid arthritis. Results of the U.S.A. - U.S.S.R. double-blind placebo-controlled trial. New England Journal of Medicine. 1992;326:1043-1049.

Giannini EH, Malagon C, Van Kerckhove C, Taylor J, Lovell DJ, Levinson JE, Passo MH, Ginsberg J, Burke M, Glass DN. Longitudinal analysis of HLA-associated risks for iridocyclitis in juvenile rheumatoid arthritis. Journal of Rheumatology. 1991;18:1394-1397.

Brewer EJ, Giannini EH, Kuzmina N, Alekseev L. D - penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis: Results of the U.S.A. - U.S.S.R. double-blind, placebo controlled trial. New England Journal of Medicine. 1986;314:1269-1276.

Giannini EH, Brewer EJ, Person DA. Auranofin in the treatment of juvenile rheumatoid arthritis. Journal of Pediatrics. 1983;102:138-141.

Giannini EH, Northey WT, Leathers CR. The allergic significance of certain fungi rarely reported as allergens. Annals of Allergy. 1975;35:372-376.